Skip to main content

Table 3 Univariate analysis of prognosis of 227 patients with pT3N0 M0 TESCC

From: Analysis of the causes of failure after radical surgery in patients with PT3N0M0 thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy

Variable

N

OS (%)

Χ2

P

LRR (%)

Χ2

P

DM (%)

Χ2

P

3yr

5yr

3yr

5yr

3yr

5yr

Sex

   

1.819

0.177

  

0.985

0.321

  

2.301

0.129

 Male

160

58.1

45.6

  

22.4

27.1

  

24.1

18.2

  

 Female

67

62.7

53.7

  

32.8

34.7

  

7.4

7.4

  

Age

   

0.513

0.474

  

0.788

0.375

  

0.172

0.678

 ≤62

120

59.2

48.3

  

27.6

32.5

  

14.7

16.0

  

 >62

107

59.8

47.7

  

24.1

26.7

  

9.0

13.7

  

Lymph node by preoperative CT

  

1.326

0.250

  

0.395

0.530

  

0.013

0.908

 No

153

58.2

46.4

  

26.1

29.8

  

10.2

14.7

  

 Yes

44

50.0

40.9

  

31.9

31.9

  

16.2

16.2

  

Lesion location

   

15.747

0.000

  

5.923

0.047

  

0.378

0.828

 Upper

33

30.3

21.2

  

49.2

55.6

  

12.6

22.3

  

 Middle

153

62.7

51.0

  

24.0

27.7

  

12.1

14.2

  

 Lowe

41

70.7

58.5

  

19.2

22.0

  

11.0

14.4

  

Lesion length(cm)

  

0.413

0.520

  

0.098

0.754

  

0.215

0.643

 ≤5

125

55.2

47.2

  

27.0

30.5

  

13.4

14.8

  

 >5

102

64.7

49.0

  

24.9

29.0

  

10.0

14.8

  

Intraoperative adhesion

   

0.487

0.485

  

0.003

0,957

  

0.237

0.627

 No/mild

130

60.0

49.2

  

25.6

29.8

  

12.0

15.8

  

 Moderate/severe

97

58.8

46.4

  

26.6

29.7

  

12.0

13.8

  

Differentiation

  

7.798

0.005

  

1.563

0.211

  

19.243

0.000

 poorly

38

44.7

26.3

  

30.8

40.0

  

31.1

40.9

  

 Moderately to well

189

62.4

52.4

  

25.0

27.9

  

8.0

9.7

  

No. of lymph nodes removed(No.)

 

2.422

0.120

  

0.001

0.978

  

0.007

0.935

 ≤10

133

57.1

43.6

  

26.9

30.3

  

12.1

14.9

  

 >10

94

62.8

54.3

  

24.9

29.1

  

11.7

14.9

 Â